The move appears to reflect the policy of the semiautonomous Chinese region to attract talent. Read more at straitstimes.com.

Trump administration's latest ban on Harvard about enrolling foreign students has invited widespread criticism from China.

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

The newest Chinese hospital ship can provide "early-stage treatment and specialized care" during wartime to reduce combat losses.

The Chinese government says the Trump administration’s move to ban international students from Harvard will harm America’s ...

Shares of Chinese companies Jiangsu Hengrui Pharmaceuticals and Mirxes Holdings rose sharply on Friday in Hong Kong trading debuts after raising a combined $1.4 billion in separate listings.

Mainland shares’ premium over Hong Kong will remain on an aggregate level, but certain stocks such as BYD and China Merchants ...

Speakers at the Hong Kong conference next week are expected to discuss economics, trade and political uncertainties.

Over 1,300 enterprises from 39 countries and regions gathered in Chongqing on May 22 for the 7th Western China International ...

Taiwan's Foxconn is among potential bidders for the Singaporean semiconductor assembly and testing business UTAC Holdings in ...

ProWine Hong Kong 2025 concluded successfully at the Hong Kong Convention and Exhibition Center. Against the backdrop ...

Editor's note: 2025 marks the centennial of Beijing's Palace Museum as a public museum transformed from the imperial palace, ...